Pharmafile Logo

Souvenaid

- PMLiVE

Eisai and Biogen’s new data shows Alzheimer’s patients choose to stay on Leqembi long-term

The findings were presented at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases in Denmark

- PMLiVE

PRGN adds OVID Health as Specialist Healthcare Member Agency

OVID Health joins PRGN, boosting patient-centred healthcare and life science communications

Grace Communications logo

GRACE COMMS acquisition of WORDBIRD creates a merger of two independent, strategic and creative healthcare agencies

We are delighted to announce that Grace Comms and Wordbird Limited, both healthcare brand comms agencies with a creative mission in healthcare and a passion for people, are coming together....

Grace Communications

- PMLiVE

Scotland becomes first part of UK to screen all newborn babies for SMA

The screening is part of a two-year evaluation funded by the Scottish government and Novartis

- PMLiVE

RedSail Technologies appoints Joy Neely as Chief Growth Officer

Neely previously worked at Medvantx, Roche and Eli Lilly

- PMLiVE

Novartis agrees on potential $3bn deal to buy Synnovations’s breast cancer treatment

The oral drug is currently being evaluated for breast cancer and other advanced solid tumours in a phase 1/2 study

- PMLiVE

Prime appoints David Hogben as SVP, Omnichannel Strategy & Delivery

Hogben has previously worked across the US and global markets

- PMLiVE

Leading with Heart: Why Vulnerability is a Force Multiplier

In a world that often prizes "macho" decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are advocating for a more human...

Medscape Education

- PMLiVE

Department of Health and Social Care and partners launch new funding initiative

The DHSC, along with a UK government department and Wellcome, aims to tackle urgent infectious disease threats

- PMLiVE

Biologos appoints Hetal Patel as CEO

The appointment coincides with Biologos’ 50th anniversary

- PMLiVE

Almirall celebrates new offices in China to advance innovation in dermatology

The company’s R&D and commercial expertise represent valuable capabilities for future Chinese partners

- PMLiVE

Lucid Group appoints former Pfizer R&D leader Rod MacKenzie as Board Chair  

Lucid’s US Medical Affairs division unveils new proprietary insights tools to expand advisory capabilities 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links